HPCwire: Thus Begins the Era of the $1,000 Genome

Since 1986 - Covering the Fastest Computers
in the World and the People Who Run Them

Translation Disclaimer

Subscribe | Sign In

Visit additional Tabor Communication Publications

Leading HPC
Solution Providers

January 11, 2012

Thus Begins the Era of the $1,000 Genome

Michael Feldman

On Tuesday, Life Technologies Corporation unveiled its newest DNA sequencer, which they claim can map a human genome in a day for a $1,000. That's just a fraction of the cost ($4,000 - $10,000) and time (two weeks or more) incurred by current platforms. Meanwhile rival Illumina Inc. has launched its latest DNA sequencing platform, which also purports to map a genome in a day. If the companies' claims hold up, such a performance increase will usher in a new era of genome sequencing.

But, as we've reported here before, interpreting those genes will limit how widely the technology can be applied. The analysis is the important step that turns the raw data into something useful, such as pointing the way to personalized drug treatment or assessing future risk of developing specific diseases.

Since such analysis requires sophisticated bioinformatics software and lots of computing muscle (that is, HPC-type hardware), this tends to be the most expensive and drawn-out step in the process. In general, interpreting the data can cost between 10 and 100 times as much as the sequencing. As was summed up rather well last year in a Genomics Law Report article:

[T]he goal is not inexpensive genomics, but personal genomics. What matters is not how much it costs to generate a genome sequence (i.e., raw data), but what you can do with that genome once you have it. Thus, genomics is only personal once both the data and the interpretation are individually tailored.

Because the analysis is costly, most analysts are skeptical that clinical genomics will be a reality anytime soon. The article quotes William Blair analyst Amanda Murphy, who believes that "the wide-scale incorporation of whole genome sequencing into the clinical realm is 10 or more years away."

Nevertheless, a glut of genomes will certainly spur demand for more "creative" solutions to the problem. The same Genomics Law Report piece points to a year-old Wired article that suggest DIY genomics will be an option for people who want to side-step the traditional health care system:

None of this is simple, but it will become easier with time. As the retail costs of sequencing drops, a substantial niche will develop for innovators providing affordable, intuitive, accurate interpretation tools (embryonic versions already exist: see, for instance, Promethease or Enlis Genomics). Open-source academic software built for large-scale sequencing projects will be adapted for use by non-specialists. The increasing availability of large-scale computing power (for instance, via Amazon EC2), coupled with this intuitive software, will make even compute-intensive analyses available to the educated, motivated lay-person.

Given the wariness traditional doctors have shown toward alternative healthcare, the medical establishment is not likely to embrace this approach. And as the article notes, such solutions are not suitable for everyone. But for those willing to educate themselves about the technology, "there's no reason why a DIY genome couldn't be every bit as useful (or indeed as useless, in many cases) as one obtained through the doctor-as-gatekeeper route."

Share Options

Subscribe

Subscribe to HPCwire

Discussion

There are 0 discussion items posted.

Join the Discussion

Become a Registered User Today!

Registered Users Log in join the Discussion

RSS Feeds

Feeds by Topic

Feeds by Industry

Feeds by Content Type

Subscribe to All Content

All

May 22, 2012

May 21, 2012

May 18, 2012

May 17, 2012

May 16, 2012

May 15, 2012

May 14, 2012

May 11, 2012

May 10, 2012

Feature Articles

OpenACC Starts to Gather Developer Mindshare

PGI, Cray, and CAPS enterprise are moving quickly to get their new OpenACC-supported compilers into the hands of GPGPU developers. At NVIDIA's GPU Technology Conference this week, there was plenty of discussion around the new HPC accelerator framework, and all three OpenACC compiler makers, as well as NVIDIA, were talking up the technology.
Read more...

NVIDIA Launches Kepler Into HPC

NVIDIA has introduced its first Kepler-generation GPU product for high performance computing, and revealed some of the inner working of the new architecture. The announcement took place at the kickoff of the company's GPU Technology Conference taking place this week in San Jose, California.
Read more...

Intel Rolls Out New Server CPUs

Intel Corp. has launched three new families of Xeon processors, joining the Xeon E5-2600 series the chipmaker introduced in March. These latest chips span the entire market for the Xeon line, from four- and two-socket servers, down to entry-level workstations and microservers. A number of HPC server makers, including SGI, Dell, and Appro announced updated hardware based on the new silicon.
Read more...